Fred Shane

Fred Shane, the managing partner of Axil Capital, is a seasoned investment professional with over 18 years of experience in the VC, PE, and investment banking industries, where he has assumed a number of key positions at multiple prominent organizations.

Early in his career, Fred was instrumental in setting up the biotech investment team within the Investment Business Department of Marubeni USA, where he gained deep experience in sourcing, evaluating, executing, and actively supporting young biotech startups through successful exits.

Subsequently, Fred joined a distressed private equity firm, where he was rapidly promoted to the co-head of the credit team and continued to manage a team of 14 investment professionals overseeing hundreds of distressed and HY credits across five funds, totaling multi-billion dollars in AUM.

Most recently, Fred served Mizuho Securities, a Japanese investment bank, in the ECM and investment business departments, from where he successfully launched Axil Capital, a life sciences VC firm.

Fred holds a B.S. degree in Electrical Engineering & Computer Science from MIT.